title: Erratum to: UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.
authors.affiliation: Department of Medical Oncology, Saku Central Hospital Advanced Care Center, 3400-28 Nakagomi, Saku, Nagano, 385‑0051, Japan. miyata.yoshinori@sakuhp.or.jp.
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Miyata
authors.affiliation: Department of Surgery, Nakagami Hospital, Okinawa, Japan.
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Touyama
authors.affiliation: Department of Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
authors.forename: Takaya
authors.initials: T
authors.lastname: Kusumi
authors.affiliation: Department of Radiology, National Hospital Organization Kobe Medical Center, Kobe, Japan.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Morita
authors.affiliation: Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Mizunuma
authors.affiliation: Hepato-Pancreatic Surgery Division, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Taniguchi
authors.affiliation: Yakult Honsha Co., Ltd., Tokyo, Japan.
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Manabe